American Regent Executive and Leadership Team

Srinivas Tetali, the Chief Medical Officer at American Regent, leads all clinical strategy and medical affairs initiatives for the company's sterile injectable product lines. Overseeing rigorous safety protocols and clinical data analysis, the Chief Medical Officer ensures that every product meets the highest standards required by healthcare providers and hospitals. This leadership role involves constant engagement with regulatory bodies and medical experts to validate the efficacy of pharmaceutical offerings. By integrating clinical insights into the product development lifecycle, Srinivas Tetali drives the advancement of therapeutic solutions that address critical patient needs across the United States and Canada. The Chief Medical Officer maintains a focus on evidence-based practices, ensuring that clinical excellence remains at the core of the company's mission. Through meticulous oversight of medical compliance and safety standards, Tetali supports the company's reputation for reliability and quality in the complex pharmaceutical manufacturing industry.

Joseph Oestreicher, the Chief People Officer at American Regent, directs all human capital strategies and organizational development initiatives across the company's diverse manufacturing and corporate locations. Overseeing talent acquisition, employee engagement, and workforce training, the Chief People Officer ensures that the organization maintains a high-performance culture capable of supporting complex pharmaceutical operations. This leadership role involves designing programs that foster professional growth and operational efficiency among staff in New York, Ohio, and Pennsylvania. By aligning human resource policies with the company's broader business objectives, Joseph Oestreicher drives the development of a skilled workforce dedicated to the production of high-quality sterile injectables. The Chief People Officer maintains a focus on building a resilient organizational structure that adapts to the changing needs of the healthcare industry. Through strategic talent management and leadership development, Oestreicher secures the human capital necessary for the company's continued success and long-term growth.

Gretchen Fritz, the Vice President, Chief Legal Officer at American Regent, directs all legal affairs, corporate governance, and regulatory compliance initiatives for the organization. Overseeing complex contract negotiations and risk management strategies, the Vice President, Chief Legal Officer ensures that all business activities align with federal and regional pharmaceutical regulations. This leadership role involves providing critical counsel to the executive team regarding intellectual property, litigation, and corporate policy. By mitigating legal risks associated with the manufacturing and distribution of sterile injectables, Gretchen Fritz drives the protection of the company's assets and market reputation across North America. The Vice President, Chief Legal Officer maintains a focus on ethical standards and regulatory transparency, ensuring that the company operates with integrity in every sales territory. Through proactive legal oversight and strategic guidance, Fritz secures the company's operational continuity and supports the achievement of long-term corporate objectives within the highly regulated healthcare sector.

Mithel Bagrecha, the Managing Director at American Regent, directs all strategic operations and business development initiatives across the organization. Overseeing the expansion of sterile injectable portfolios, the Managing Director ensures alignment with the broader goals of the Daiichi Sankyo Group. This leadership role involves optimizing manufacturing output across facilities in New York, Ohio, and Pennsylvania to meet the evolving demands of healthcare providers. By fostering cross-functional collaboration, Mithel Bagrecha drives operational excellence and sustainable growth within the competitive pharmaceutical landscape. The Managing Director maintains a focus on long-term market stability, ensuring that the company delivers consistent value to hospitals and clinics nationwide. Through precise resource allocation and strategic oversight, Bagrecha secures the company's position as a premier supplier of essential medical products, ultimately strengthening the overall impact of the organization on the North American healthcare sector.